C
Citius Pharmaceuticals, Inc. (CTXR)
NCM – Real vaqt narxi. Valyuta: USD
0.61
-0.03 (-4.01%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.61
-0.03 (-4.01%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Citius Pharmaceuticals, Inc., biotexnologiya kompaniyasi, intensiv terapiya mahsulotlarini ishlab chiqish va tijoratlashtirishga qaratilgan. FDA tomonidan tasdiqlangan LYMPHIR mahsuloti, teri T-hujayrali limfoma davolash uchun mo'ljallangan immunoterapiya hisoblanadi. Kompaniyaning keyingi bosqichdagi mahsulotlari qatoriga kateter bilan bog'liq qon oqimi infeksiyalarini davolash uchun antibiotik blokirovka eritmasi bo'lgan Mino-Lok; gemorroydan aziyat chekayotgan shaxslarga yallig'lanishga qarshi va og'riqsizlantiruvchi yordam ko'rsatish uchun kortikosteroid-lidokainli topik preparat bo'lgan Halo-Lido; va ARDSni davolash uchun mezenxima ildiz hujayralari terapiyasi bo'lgan NoveCite kiradi. Citius Pharmaceuticals, Inc. 2007-yilda tashkil etilgan va Nyu-Jersi shtatining Cranford shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Alan Lader Ph.D. | Senior VP and Head of Clinical Operations & Quality Assurance |
| Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
| Mr. Dhananjay G. Wadekar | Senior Vice President of Business Strategy |
| Mr. Gary F. Talarico | Executive Vice President of Operations |
| Mr. Jaime Bartushak | Chief Business Officer & CFO |
| Mr. Kelly Creighton Ph.D. | Executive Vice President of Chemistry, Manufacturing & Controls |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 8-K | ea0289731-8k_citius.htm |
| 2026-04-29 | 8-K | ea0288203-8k_citius.htm |
| 2026-04-24 | 8-K | ea0287620-8k_citius.htm |
| 2026-04-06 | 8-K | ea0285222-8k_citius.htm |
| 2026-03-31 | 8-K | ea0284323-8k_citius.htm |
| 2026-03-10 | 8-K | ea0280664-8k_citius.htm |
| 2026-03-04 | 8-K | ea0277422-8k_citius.htm |
| 2026-02-24 | DEFA14A | ea02772491-defa14a_citius.htm |
| 2026-02-24 | DEF 14A | ea0277108-def14a_citius.htm |
| 2026-02-13 | 8-K | ea0276948-8k_citius.htm |
| Mr. Leonard L. Mazur | Co-Founder, CEO, Chairman & Secretary |
| Mr. Myron Z. Holubiak | Co-Founder & Executive Vice Chairman |
| Mr. Nikolas Burlew | Executive Vice President of Quality Assurance |
| Ms. Ilanit Allen | Vice President of Investor Relations & Corporate Communications |